RxBenefits on the ULA Network

Can Labor Unions and Funds Effectively Manage the Cost Impact of GLP-1s?

GLP-1 medications like Ozempic®, Wegovy®, and Mounjaro® are transforming treatment for diabetes and obesity, but their rising popularity has also introduced new challenges for union-sponsored health plans.

In this featured resource available through our partnership with the ULA Network, we explore how labor unions and funds can optimize their approach to managing GLP-1 utilization with strategies that help protect plan budgets, promote appropriate use, and safeguard long-term member access.

This article covers:

• Why GLP-1s are driving increased pharmacy spending and what’s fueling demand 

• How plan revisions like prior authorization review and step therapy help curb inappropriate use 

• Why educating members is key to promoting informed choices and better outcomes 

• Actionable steps unions and funds can take to manage costs without compromising care 

Read the full blog on the ULA Network to explore strategies for responsible GLP-1 management.